TrialmSystems2026

Additive effects of fecal microbiota transplantation and infliximab on gut microbiome and metabolome in refractory inflammatory bowel disease patients.

Xinjun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.